RFC
GSK icon

Regions Financial Corp’s GSK GSK Stock Holding History

Regions Financial Corp’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.71M Buy
31,024
+1,438
+5% +$77.9K 0.01% 392
2025
Q4 		$1.45M Sell
29,586
-37
-0.1% -$1.73K 0.01% 432
2025
Q3 		$1.28M Sell
29,623
-1,601
-5% -$62.5K 0.01% 462
2025
Q2 		$1.2M Buy
31,224
+1,397
+5% +$53.4K 0.01% 469
2025
Q1 		$1.16M Sell
29,827
-788
-3% -$28.8K 0.01% 462
2024
Q4 		$1.04M Buy
30,615
+611
+2% +$22K 0.01% 473
2024
Q3 		$1.23M Buy
30,004
+4,315
+17% +$177K 0.01% 454
2024
Q2 		$989K Sell
25,689
-347
-1% -$14.6K 0.01% 473
2024
Q1 		$1.12M Buy
26,036
+668
+3% +$27.5K 0.01% 475
2023
Q4 		$940K Buy
25,368
+815
+3% +$29.3K 0.01% 485
2023
Q3 		$890K Buy
24,553
+353
+1% +$12.5K 0.01% 475
2023
Q2 		$862K Sell
24,200
-4,168
-15% -$150K 0.01% 498
2023
Q1 		$1.01M Buy
28,368
+6,547
+30% +$229K 0.01% 476
2022
Q4 		$767K Buy
+21,821
New +$727K 0.01% 522
2022
Q3 		– Sell
-24,898
Closed -$1.35M – 845
2022
Q2 		$1.35M Buy
24,898
+775
+3% +$42.8K 0.01% 424
2022
Q1 		$1.31M Buy
24,123
+871
+4% +$47.3K 0.01% 458
2021
Q4 		$1.28M Sell
23,252
-134
-0.6% -$6.97K 0.01% 463
2021
Q3 		$1.12M Sell
23,386
-994
-4% -$49.9K 0.01% 460
2021
Q2 		$1.21M Buy
24,380
+2,094
+9% +$101K 0.01% 446
2021
Q1 		$994K Buy
22,286
+1,026
+5% +$46.6K 0.01% 473
2020
Q4 		$978K Sell
21,260
-1,970
-8% -$90.5K 0.01% 459
2020
Q3 		$1.09M Sell
23,230
-402
-2% -$20.1K 0.01% 397
2020
Q2 		$1.21M Buy
23,632
+50
+0.2% +$2.56K 0.01% 376
2020
Q1 		$1.12M Sell
23,582
-3,257
-12% -$174K 0.01% 351
2019
Q4 		$1.58M Buy
26,839
+149
+0.6% +$8.29K 0.02% 340
2019
Q3 		$1.42M Buy
26,690
+2,408
+10% +$124K 0.02% 339
2019
Q2 		$1.21M Sell
24,282
-836
-3% -$41.9K 0.01% 371
2019
Q1 		$1.31M Sell
25,118
-552
-2% -$27.6K 0.02% 356
2018
Q4 		$1.23M Sell
25,670
-664
-3% -$32.7K 0.02% 343
2018
Q3 		$1.32M Sell
26,334
-1,986
-7% -$101K 0.01% 372
2018
Q2 		$1.43M Sell
28,320
-1,012
-3% -$51K 0.02% 356
2018
Q1 		$1.43M Sell
29,332
-693
-2% -$32.3K 0.02% 359
2017
Q4 		$1.33M Buy
30,025
+431
+1% +$19.9K 0.01% 384
2017
Q3 		$1.5M Sell
29,594
-2,123
-7% -$108K 0.02% 350
2017
Q2 		$1.71M Sell
31,717
-730
-2% -$38.9K 0.02% 325
2017
Q1 		$1.71M Buy
32,447
+2,086
+7% +$106K 0.02% 340
2016
Q4 		$1.46M Sell
30,361
-189
-0.6% -$9.34K 0.02% 394
2016
Q3 		$1.65M Sell
30,550
-2,259
-7% -$124K 0.02% 342
2016
Q2 		$1.78M Buy
32,809
+299
+0.9% +$15.8K 0.02% 315
2016
Q1 		$1.65M Buy
32,510
+1,627
+5% +$81K 0.02% 355
2015
Q4 		$1.56M Buy
30,883
+349
+1% +$17.8K 0.02% 380
2015
Q3 		$1.47M Sell
30,534
-614
-2% -$32K 0.02% 392
2015
Q2 		$1.62M Buy
31,148
+331
+1% +$18.6K 0.02% 386
2015
Q1 		$1.78M Sell
30,817
-4,215
-12% -$242K 0.02% 361
2014
Q4 		$1.87M Buy
35,032
+6,566
+23% +$367K 0.02% 333
2014
Q3 		$1.64M Sell
28,466
-25,550
-47% -$1.57M 0.02% 413
2014
Q2 		$3.61M Sell
54,016
-569
-1% -$38.5K 0.04% 232
2014
Q1 		$3.65M Buy
54,585
+175
+0.3% +$11.8K 0.05% 225
2013
Q4 		$3.63M Buy
54,410
+20,668
+61% +$1.34M 0.04% 234
2013
Q3 		$2.12M Sell
33,742
-907
-3% -$58.4K 0.03% 312
2013
Q2 		$2.17M Buy
+34,649
New +$2.2M 0.03% 283

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Regions Financial Corp's GSK Position: Q1 2026 in Review

Regions Financial Corp increased its GSK (GSK) stake by 4.9% in Q1 2026, buying an estimated $77.9K and bringing the position to 31,024 shares worth $1.71M. The position accounts for 0.01% of the portfolio, ranked #392.

Regions Financial Corp first reported a position in GSK in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.65M in Q1 2014. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Regions Financial Corp held 31,024 shares of GSK worth $1.71M as of Q1 2026.
  • Regions Financial Corp bought 1,438 GSK shares in Q1 2026, an estimated $77.9K.
  • GSK made up 0.01% of Regions Financial Corp's portfolio in Q1 2026, its #392 holding.
  • Regions Financial Corp first reported a position in GSK in Q2 2013 and has held it in 51 quarters since.
  • Regions Financial Corp's GSK position peaked at $3.65M in Q1 2014.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Regions Financial Corp's 13F filing for Q1 2026, filed 5 May 2026.